Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs… TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: Read More
LONG BEACH, Calif. and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.Read More
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a Read More
Avicannas evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicannas 2025 advances across R&D, clinical development, and Read More
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (LEEF or the Company), a leading multi-state Read More
Announces Termination of its Previously Announced Agreement with Curaleaf CHELMSFORD, Mass. — The Cannabist Company Holdings Inc. (Cboe CA: CBST) (OTCQB: Read More
TORONTO Stock markets in Canada and the U.S. rose on Thursday following the release of key U.S. economic Read More
VANCOUVER, British Columbia, Dec. 18, 2025 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), Read More
Move to Schedule III Expected to Bring in More Investment Interest and Capital to Publicly-Traded Companies Like POSaBIT THIS CONTENT Read More
Schedule 3 drugs: President Trump signed an executive order to reclassify marijuana to Schedule III, aiming to expand medical research into Read More
Be the first to receive the latest buzz contests & more!